Combination Ruxolitinib and Belumosudil Is Tolerable and Induces Responses Despite Treatment Failure As Monotherapies
- Resource Type
- Abstract
- Source
- In
Transplantation and Cellular Therapy February 2024 30(2) Supplement:S285-S285 - Subject
- Language
- ISSN
- 2666-6367